Haematological malignancies implications during the times of the COVID-19 pandemic

The COVID-19 pandemic has complicated current healthcare services for cancer patients. Patients with haematological malignancies specifically seem vulnerable to SARS-CoV-2 infection due to their immunosuppressed status. The COVID-19 pandemic influences every step of the assessment and treatment of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Papakonstantinou, Eleni, Dragoumani, Konstantina, Efthimiadou, Aspasia, Palaiogeorgou, Anastasia Marina, Pierouli, Katerina, Mitsis, Thanasis, Chrousos, George P., Bacopoulou, Flora, Vlachakis, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581473/
https://www.ncbi.nlm.nih.gov/pubmed/34777590
http://dx.doi.org/10.3892/ol.2021.13117
_version_ 1784596816907468800
author Papakonstantinou, Eleni
Dragoumani, Konstantina
Efthimiadou, Aspasia
Palaiogeorgou, Anastasia Marina
Pierouli, Katerina
Mitsis, Thanasis
Chrousos, George P.
Bacopoulou, Flora
Vlachakis, Dimitrios
author_facet Papakonstantinou, Eleni
Dragoumani, Konstantina
Efthimiadou, Aspasia
Palaiogeorgou, Anastasia Marina
Pierouli, Katerina
Mitsis, Thanasis
Chrousos, George P.
Bacopoulou, Flora
Vlachakis, Dimitrios
author_sort Papakonstantinou, Eleni
collection PubMed
description The COVID-19 pandemic has complicated current healthcare services for cancer patients. Patients with haematological malignancies specifically seem vulnerable to SARS-CoV-2 infection due to their immunosuppressed status. The COVID-19 pandemic influences every step of the assessment and treatment of a haematological malignancy. Clinicians must adhere to strict policies to not spread the virus to their patients while they must also adjust their workflow for maximum productivity. These difficulties accentuate the ever-present need to improve the healthcare services for cancer patients. This improvement is needed not only to combat the problems that arose from the COVID-19 pandemic but also to establish a framework for the management of patients with haematological malignancies in potential future pandemics.
format Online
Article
Text
id pubmed-8581473
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-85814732021-11-12 Haematological malignancies implications during the times of the COVID-19 pandemic Papakonstantinou, Eleni Dragoumani, Konstantina Efthimiadou, Aspasia Palaiogeorgou, Anastasia Marina Pierouli, Katerina Mitsis, Thanasis Chrousos, George P. Bacopoulou, Flora Vlachakis, Dimitrios Oncol Lett Review The COVID-19 pandemic has complicated current healthcare services for cancer patients. Patients with haematological malignancies specifically seem vulnerable to SARS-CoV-2 infection due to their immunosuppressed status. The COVID-19 pandemic influences every step of the assessment and treatment of a haematological malignancy. Clinicians must adhere to strict policies to not spread the virus to their patients while they must also adjust their workflow for maximum productivity. These difficulties accentuate the ever-present need to improve the healthcare services for cancer patients. This improvement is needed not only to combat the problems that arose from the COVID-19 pandemic but also to establish a framework for the management of patients with haematological malignancies in potential future pandemics. D.A. Spandidos 2021-12 2021-10-29 /pmc/articles/PMC8581473/ /pubmed/34777590 http://dx.doi.org/10.3892/ol.2021.13117 Text en Copyright: © Papakonstantinou et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Review
Papakonstantinou, Eleni
Dragoumani, Konstantina
Efthimiadou, Aspasia
Palaiogeorgou, Anastasia Marina
Pierouli, Katerina
Mitsis, Thanasis
Chrousos, George P.
Bacopoulou, Flora
Vlachakis, Dimitrios
Haematological malignancies implications during the times of the COVID-19 pandemic
title Haematological malignancies implications during the times of the COVID-19 pandemic
title_full Haematological malignancies implications during the times of the COVID-19 pandemic
title_fullStr Haematological malignancies implications during the times of the COVID-19 pandemic
title_full_unstemmed Haematological malignancies implications during the times of the COVID-19 pandemic
title_short Haematological malignancies implications during the times of the COVID-19 pandemic
title_sort haematological malignancies implications during the times of the covid-19 pandemic
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581473/
https://www.ncbi.nlm.nih.gov/pubmed/34777590
http://dx.doi.org/10.3892/ol.2021.13117
work_keys_str_mv AT papakonstantinoueleni haematologicalmalignanciesimplicationsduringthetimesofthecovid19pandemic
AT dragoumanikonstantina haematologicalmalignanciesimplicationsduringthetimesofthecovid19pandemic
AT efthimiadouaspasia haematologicalmalignanciesimplicationsduringthetimesofthecovid19pandemic
AT palaiogeorgouanastasiamarina haematologicalmalignanciesimplicationsduringthetimesofthecovid19pandemic
AT pieroulikaterina haematologicalmalignanciesimplicationsduringthetimesofthecovid19pandemic
AT mitsisthanasis haematologicalmalignanciesimplicationsduringthetimesofthecovid19pandemic
AT chrousosgeorgep haematologicalmalignanciesimplicationsduringthetimesofthecovid19pandemic
AT bacopoulouflora haematologicalmalignanciesimplicationsduringthetimesofthecovid19pandemic
AT vlachakisdimitrios haematologicalmalignanciesimplicationsduringthetimesofthecovid19pandemic

Ejemplares similares